Stay updated on Guselkumab in Psoriasis: Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.

Latest updates to the Guselkumab in Psoriasis: Clinical Trial page
- Check5 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedMinimal site update detected: Revision: v3.4.2 was added and the government funding lapse notice was removed. No changes were made to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded a government funding notice about potential delays in updating information and site operations. Updated the site revision tag to v3.4.1, replacing v3.4.0.SummaryDifference0.2%

- Check48 days agoChange DetectedShow glossary has been added to the page, and the QC-related metadata has been updated to display 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a revision note 'Revision: v3.4.0'. These changes are minor UI and wording updates and do not alter the study content, eligibility criteria, or results.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, indicating a minor update to the page. No study data, eligibility criteria, or results appear to be affected.SummaryDifference0.0%

- Check84 days agoChange DetectedLocations were expanded to include site entries across multiple US states and Ontario. Older per-location entries (e.g., Alabama Locations, Ontario Locations) were removed, and a new Revision: v3.3.3 tag appears.SummaryDifference1%

Stay in the know with updates to Guselkumab in Psoriasis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.